Arturo Molina M.D. is Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX). They have made 10 open-market trades across 2 companies since 2020, most recently 2026-03-26.
CIK 0001398940
1 open-market purchase totalling $50K since 2020, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTGX | 84,115 | $10.8M |
| STRO | 42,091 | $459K |
| FMTX | 10,000 | $200K |
| Total | $11.5M |
Shares reported on the most recent Form 4, priced at the 2026-03-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTGX | SELL | 2026-03-26 | 2026-03-27 | $104.79 | $1.6M | +5.1% | -0.5% | +23.8% |
| PTGX | SELL | 2026-01-23 | 2026-01-27 | $82.30 | $1.9M | +2.5% | +7.2% | +19.5% |
| PTGX | SELL | 2026-01-20 | 2026-01-21 | $82.48 | $785K | +0.3% | -0.1% | +27.8% |
| PTGX | SELL | 2025-11-17 | 2025-11-19 | $84.77 | $460K | -2.0% | -0.4% | -4.5% |
| PTGX | SELL | 2025-06-09 | 2025-06-11 | $56.27 | $1.1M | -2.7% | -3.9% | +5.8% |
| PTGX | SELL | 2025-03-13 | 2025-03-14 | $55.74 | $3.4M | -8.5% | -16.9% | +4.0% |
| PTGX | SELL | 2024-11-26 | 2024-11-27 | $44.97 | $1.7M | -6.7% | -12.6% | -21.3% |
| PTGX | SELL | 2024-11-15 | 2024-11-19 | $40.98 | $156K | +13.0% | +3.3% | -1.4% |
| PTGX | SELL | 2023-11-15 | 2024-01-04 | $16.24 | $30K | +8.8% | +14.6% | +23.7% |
| STRO | BUY | 2020-05-14 | 2020-05-14 | $7.75 | $50K | +10.3% | +9.3% | +1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.